Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

269

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

April 30, 2013

Conditions
SchizophreniaCognitive Effect on Schizophrenic Patients
Interventions
DRUG

CYP-1020

CYP-1020 (formerly known as BL-1020) is an orally available new chemical entity.

DRUG

Risperidone

Trial Locations (39)

Unknown

Department of Psychiatry, Sheath VS General Hospital, Sheath KM School of Post Graduate Medicine & Research, Ahmedabad

Saoji Tupkari Hospital, Aurangabad

Spandana Nursing Home, Bangalore

KHM Hospital, Chennai

Asha Hospital, Hyderabad

Department of Psychiatry, Owaisi Hospital & Research Centre, Hyderabad

RK Yadav Memorial Mental Health and De-addiction Hospital, Jaipur

Mahendru Psychiatric Centre, Kanpur

Dreamland Nursing Home, Kolkata

Dayanand Medical College & Hospital, Ludhiana

Centre for Psychiatric Research, Department of Psychiatry, K.S Hegde Medical Academy, Mangalore

Jaslok Hospital&Research Centre, Mumbai

JSS Medical College Hospital, Mysore

Sujata Birla Hospital, Nashik

Vimhans Hospital, New Delhi

S.V.Medical College, Tirupati

Deva Mental Health Care, Varanasi

Vijayawada Institute of Mental Health & Neurosciences, Vijayawada

IMSP Spitalul Clinic de Psihiatrie, Sectia 14, Chisinau

IMSP Spitalul Clinic de Psihiatrie, Sectia 17, Chisinau

IMSP Spitalul Clinic de Psihiatrie, Sectia 8, Chisinau

pitalul Clinic Judetean de Urgenta Arad Clinica Psihiatrie, Arad

Spitalul de Psihiatrie si Neurologie Brasov, Brasov

"Spitalul Clinic de Psihiatrie Prof. Dr. Al. Obregia", Bucharest

Spitalul Clinic de Psihiatrie Dr. Alexandru Obregia Department 13, Bucharest

Spitalul Clinic de Psihiatrie Dr. Alexandru Obregia Department 1, Bucharest

Spitalul Clinic de Psihiatrie Dr. Alexandru Obregia Department 8, Bucharest

Spitalul Clinic de Psihiatrie Dr. Alexandru Obregia Department 9, Bucharest

"Spitalul de Psihiatrie C.E.T.T.T. Sf. Stelian", Bucharest

Spitalul Judetean Cluj Napoca, Cluj-Napoca

Spitalul Clinic Judetean de Urgenta Constanţa Clinica de Psihiatrie, Constanța

Spitalul Clinic de Neuropsihiatrie Clinica de Psihiatrie nr. 2, Craiova

Spitalul de Neuropsihiatrie Clinica de Psihiatrie I, Craiova

Spitalul Clinic de Psihiatrie Socola, Iași

Spital Clinic de Neurologie si Psihiatrie Oradea, Oradea

"Spitalul Clinic Municipal Dr.Gavril Curteanu Oradea", Oradea

"Spitalul de Psihiatrie Dr. Gh. Preda", Sibiu

Spitalul Judetean de Urgenta Targoviste Clinica Psihiatrie Adulti nr. 7, Târgovişte

Spitalul Clinic Judetean Mures, Clinica Psihiatrie Nr. 2, Târgu Mureş

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BioLineRx, Ltd.

INDUSTRY

NCT01363349 - Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia | Biotech Hunter | Biotech Hunter